Physician profile
Jason Jones
NPI 1497791149
$1,464.42
in general payments reported to CMS, 2019-2025
23 companies · $25.25 in 2025
The $25.25 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $440 · 2021: $289 · 2022: $54.72 · 2023: $13.78 · 2025: $25.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $222.52 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $187.00 | 2019-2021 | |
| Pfizer INC. | $161.13 | 2019-2021 | |
| Amgen INC. | $150.41 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $101.28 | 2019-2021 | |
| Boston Scientific Corporation | $95.87 | 2019-2021 | |
| Allergan, INC. | $77.02 | 2019-2020 | |
| Glaxosmithkline, LLC. | $61.95 | 2020-2021 | |
| Abbvie INC. | $54.72 | 2022 | |
| Salvin Dental Specialties, INC. | $51.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.97 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.07 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.17 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $30.32 | 2020 | |
| Nestle Healthcare Nutrition INC. | $28.06 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $21.96 | 2019 | |
| Medtronic Vascular, INC. | $19.00 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $17.29 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.52 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.69 | 2019 | |
| Medtronic USA, INC. | $13.61 | 2020 | |
| Sanofi Pasteur INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.